Advanced practice nurse management in multiple myeloma treated with oral therapy

被引:3
作者
Sapet, Manon [1 ,4 ]
Migala, Cecile [2 ]
Daguenet, Elisabeth [3 ]
Collet, Philippe [3 ]
Boussoualim, Karima [1 ]
Thomas, Thierry [1 ]
Guyotat, Denis [3 ]
Augeul-Meunier, Karine [3 ]
机构
[1] Univ Hosp St Etienne, Dept Rheumatol, F-42055 St Etienne 2, France
[2] Canc Inst Lucien Neuwirth, Coordinat Platform, St Priest En Jarez, France
[3] Canc Inst Lucien Neuwirth, Hematol Dept, St Priest En Jarez, France
[4] CHU St Etienne, Dept Rheumatol, F-42055 St Etienne 2, France
关键词
Advanced practice nurse; Multiple myeloma; Oral chemotherapy; Safety monitoring; Side-effect management; Remote follow-up; LENALIDOMIDE PLUS DEXAMETHASONE; LED FOLLOW-UP; MEDICATION ADHERENCE; ANTICANCER AGENTS; LUNG-CANCER; INTERVENTION; CHEMOTHERAPY; PERCEPTIONS; FRAMEWORK; SAFETY;
D O I
10.1016/j.bulcan.2023.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction > Therapeutic approaches in Multiple Myeloma (MM) have considerably changed over the last few years, with effective oral chemotherapy and continuous treatment. In this context, the objective of this study was to examine the circuitry of an advanced practitioner nurse (APN)-led intervention that provided supportive care for MM patients treated with oral chemotherapy.Methods > This population-based study was conducted at the hematology department - Institut de Cancerologie Lucien Neuwirth (ICLN, Saint-Priest-en-Jarez), from April 2017 to September 2020. A follow-up program was established with a specialized APN in oncology. Results > All APN interventions were recorded, representing 1240 phone calls and 162 consulta-tions for 42 MM patients. Eighty-two calls were referred to the physician with 45 consultations triggered. Most of the calls were frequent within the few first months, with a high request for information and reassurance, especially for treatment-naive or relapsed patients. In our study, the APN was able to manage multiple side effects through care organization (i.e., hospitalizations, transfusions) and a careful coordination between the primary care team and the hospital.Discussion > In order to respond to the high need for care pathway and safety improvement, especially in elderly population, we have initiated an original follow-up by an APN for MM patients treated with oral chemotherapy. While the role of APN has become prominent in the oncology field in recent years, its holistic approach has to be emphasized in further studies to bring a compre-hensive perspective to health care coordination in the future.
引用
收藏
页码:1251 / 1259
页数:9
相关论文
共 35 条
  • [1] [Anonymous], 2015, J Hematol Oncol Pharm
  • [2] [Anonymous], 2019, Les cancers en France en 2018 - l'essentiel des faits et chiffres
  • [3] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [4] Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
    Attal, Michel
    Lauwers-Cances, Valerie
    Marit, Gerald
    Caillot, Denis
    Moreau, Philippe
    Facon, Thierry
    Stoppa, Anne Marie
    Hulin, Cyrille
    Benboubker, Lofti
    Garderet, Laurent
    Decaux, Olivier
    Leyvraz, Serge
    Vekemans, Marie-Christiane
    Voillat, Laurent
    Michallet, Mauricette
    Pegourie, Brigitte
    Dumontet, Charles
    Roussel, Murielle
    Leleu, Xavier
    Mathiot, Claire
    Payen, Catherine
    Avet-Loiseau, Herve
    Harousseau, Jean-Luc
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) : 1782 - 1791
  • [5] Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
    Benboubker, Lotfi
    Dimopoulos, Meletios A.
    Dispenzieri, Angela
    Catalano, John
    Belch, Andrew R.
    Cavo, Michele
    Pinto, Antonello
    Weisel, Katja
    Ludwig, Heinz
    Bahlis, Nizar
    Banos, Anne
    Tiab, Mourad
    Delforge, Michel
    Cavenagh, Jamie
    Geraldes, Catarina
    Lee, Je-Jung
    Chen, Christine
    Oriol, Albert
    de la Rubia, Javier
    Qiu, Lugui
    White, Darrell J.
    Binder, Daniel
    Anderson, Kenneth
    Fermand, Jean-Paul
    Moreau, Philippe
    Attal, Michel
    Knight, Robert
    Chen, Guang
    Van Oostendorp, Jason
    Jacques, Christian
    Ervin-Haynes, Annette
    Avet-Loiseau, Herve
    Hulin, Cyrille
    Facon, Thierry
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (10) : 906 - 917
  • [6] Policy statement on multidisciplinary cancer care
    Borras, Josep M
    Albreht, Tit
    Audisio, Riccardo
    Briers, Erik
    Casali, Paolo
    Esperou, Helene
    Grube, Birgitte
    Hamoir, Marc
    Henning, Geoffrey
    Kelly, Joan
    Knox, Susan
    Nabal, Maria
    Pierotti, Marco
    Lombardo, Claudio
    van Harten, Wim
    Poston, Graeme
    Prades, Joan
    Sant, Milena
    Travado, Luzia
    Valentini, Vincenzo
    van de Velde, Cornelis
    van den Bogaert, Saskia
    van den Bulcke, Marc
    van Hoof, Elke
    van den Neucker, Ingrid
    Wilson, Robin
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (03) : 475 - 480
  • [7] Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)
    Bouleftour, Wafa
    Muron, Thierry
    Guillot, Aline
    Tinquaut, Fabien
    Rivoirard, Romain
    Jacquin, Jean-Philippe
    Saban-Roche, Lea
    Boussoualim, Karima
    Tavernier, Emmanuelle
    Augeul-Meunier, Karine
    Collard, Olivier
    Mery, Benoite
    Pupier, Sidonie
    Oriol, Mathieu
    Bourmaud, Aurelie
    Fournel, Pierre
    Vassal, C.
    [J]. SUPPORTIVE CARE IN CANCER, 2021, 29 (08) : 4257 - 4267
  • [8] A framework for the introduction and evaluation of advanced practice nursing roles
    Bryant-Lukosius, D
    DiCenso, A
    [J]. JOURNAL OF ADVANCED NURSING, 2004, 48 (05) : 530 - 540
  • [9] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
    Chen, Christine
    Reece, Donna E.
    Siegel, David
    Niesvizky, Ruben
    Boccia, Ralph V.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Richardson, Paul
    Matous, Jeffrey
    Kumar, Shaji
    Bahlis, Nizar J.
    Alsina, Melissa
    Vescio, Robert
    Coutre, Steven E.
    Pietronigro, Dennis
    Knight, Robert D.
    Zeldis, Jerome B.
    Rajkumar, Vincent
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170
  • [10] Delamaire M., 2010, OECD HLTH WORKING PA, DOI [10.1787/5kmbrcfms5g7-en, DOI 10.1787/5KMBRCFMS5G7-EN]